Saturna Capital Raised Sensata Technologies Holding (ST) Holding; Glaukos (GKOS) Covered By 7 Bulls

May 18, 2018 - By Orlando Nugent

Sensata Technologies Holding PLC (NYSE:ST) Logo

Among 8 analysts covering Glaukos Corporation (NYSE:GKOS), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Glaukos Corporation had 39 analyst reports since August 13, 2015 according to SRatingsIntel. Piper Jaffray maintained the shares of GKOS in report on Wednesday, January 10 with “Buy” rating. The stock has “Buy” rating by Stephens on Thursday, March 1. The firm has “Hold” rating by Stifel Nicolaus given on Friday, April 8. The stock has “Buy” rating by BMO Capital Markets on Wednesday, April 12. Piper Jaffray maintained Glaukos Corporation (NYSE:GKOS) on Tuesday, October 24 with “Buy” rating. Cantor Fitzgerald initiated the shares of GKOS in report on Friday, June 3 with “Buy” rating. On Monday, February 26 the stock rating was maintained by Stifel Nicolaus with “Buy”. On Thursday, March 2 the stock rating was maintained by Cantor Fitzgerald with “Overweight”. On Thursday, March 1 the stock rating was maintained by BMO Capital Markets with “Outperform”. The rating was maintained by Cantor Fitzgerald with “Buy” on Friday, March 23. See Glaukos Corporation (NYSE:GKOS) latest ratings:

30/04/2018 Broker: J.P. Morgan Rating: Buy New Target: $49.0000
13/04/2018 Broker: Stifel Nicolaus Old Rating: Buy New Rating: Hold Old Target: $39 Downgrade
23/03/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $43.0000 Maintain
01/03/2018 Broker: Stephens Rating: Buy New Target: $36.0 Maintain
01/03/2018 Broker: BMO Capital Markets Old Rating: Outperform New Rating: Outperform Old Target: $38 New Target: $36 Maintain
26/02/2018 Broker: Stifel Nicolaus Old Rating: Buy New Rating: Buy Old Target: $42 New Target: $39 Maintain
23/02/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $39.0 Maintain
10/01/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $48.0 Maintain
10/01/2018 Broker: Piper Jaffray Rating: Buy New Target: $35.0 Maintain
27/12/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $48.0 Maintain

Saturna Capital Corp increased Sensata Technologies Holding (ST) stake by 139.15% reported in 2017Q4 SEC filing. Saturna Capital Corp acquired 7,222 shares as Sensata Technologies Holding (ST)’s stock declined 1.54%. The Saturna Capital Corp holds 12,412 shares with $634,000 value, up from 5,190 last quarter. Sensata Technologies Holding now has $9.34 billion valuation. The stock decreased 0.51% or $0.27 during the last trading session, reaching $52.71. About 124,869 shares traded. Sensata Technologies Holding PLC (NYSE:ST) has risen 18.02% since May 18, 2017 and is uptrending. It has outperformed by 6.47% the S&P500.

More recent Glaukos Corporation (NYSE:GKOS) news were published by: Globenewswire.com which released: “New Research Coverage Highlights Ellie Mae, Micron Technology, Applied Optoelectronics, Acadia Realty Trust …” on May 16, 2018. Also Seekingalpha.com published the news titled: “Glaukos’ (GKOS) CEO Thomas Burns on Q1 2018 Results – Earnings Call Transcript” on May 10, 2018. Ocbj.com‘s news article titled: “Midday Stock Roundup” with publication date: May 10, 2018 was also an interesting one.

The stock increased 1.22% or $0.42 during the last trading session, reaching $34.92. About 58,841 shares traded. Glaukos Corporation (NYSE:GKOS) has declined 40.30% since May 18, 2017 and is downtrending. It has underperformed by 51.85% the S&P500.

Glaukos Corporation, an ophthalmic medical technology company, focuses on the development and commercialization of products and procedures designed to treat glaucoma. The company has market cap of $1.22 billion. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. It currently has negative earnings. The companyÂ’s product pipeline includes iStent Inject trabecular micro-bypass stent that allows the surgeon to inject stents into various trabecular meshwork locations through a single corneal entry with the goal of achieving intraocular pressure reduction; iStent Supra suprachoroidal micro-bypass stent, which is designed to reduce intraocular pressure by accessing the suprachoroidal space in the eye; and iDose, a targeted injectable drug delivery implant that is designed to be pre-loaded into a small gauge needle and injected into the eye through a self-sealing corneal needle penetration.

Investors sentiment decreased to 1.42 in 2017 Q4. Its down 0.12, from 1.54 in 2017Q3. It is negative, as 20 investors sold ST shares while 73 reduced holdings. 45 funds opened positions while 87 raised stakes. 180.80 million shares or 1.57% more from 178.00 million shares in 2017Q3 were reported. Asset Mgmt One reported 242,738 shares. State Board Of Administration Of Florida Retirement stated it has 159,722 shares or 0.02% of all its holdings. 15,274 were accumulated by Oppenheimer And Inc. Citadel Ltd Liability has invested 0% in Sensata Technologies Holding PLC (NYSE:ST). The Texas-based Teacher Retirement Systems Of Texas has invested 0.02% in Sensata Technologies Holding PLC (NYSE:ST). Sentry Invs holds 0.96% or 1.48 million shares in its portfolio. Aperio Group Inc Lc has 21,568 shares. Hussman Strategic Advsrs invested in 1,200 shares. State Street invested 0.01% of its portfolio in Sensata Technologies Holding PLC (NYSE:ST). 15,667 are held by Robeco Institutional Asset Bv. Redmond Asset Mgmt Ltd Limited Liability Company owns 66,155 shares for 1.45% of their portfolio. First Republic Inv reported 0.03% of its portfolio in Sensata Technologies Holding PLC (NYSE:ST). Peak6 LP stated it has 5,374 shares or 0% of all its holdings. Rudman Errol M invested 1.44% in Sensata Technologies Holding PLC (NYSE:ST). Amundi Pioneer Asset Mgmt owns 272,939 shares.

Among 15 analysts covering Sensata Technologies Holdings NV (NYSE:ST), 7 have Buy rating, 0 Sell and 8 Hold. Therefore 47% are positive. Sensata Technologies Holdings NV had 61 analyst reports since July 30, 2015 according to SRatingsIntel. The stock of Sensata Technologies Holding PLC (NYSE:ST) has “Market Perform” rating given on Thursday, January 21 by Wells Fargo. The stock has “Sector Perform” rating by RBC Capital Markets on Monday, January 18. Barclays Capital maintained the shares of ST in report on Friday, February 2 with “Overweight” rating. RBC Capital Markets maintained it with “Buy” rating and $52.0 target in Thursday, October 12 report. The firm has “Market Perform” rating by BMO Capital Markets given on Wednesday, December 13. The stock of Sensata Technologies Holding PLC (NYSE:ST) earned “Buy” rating by Stifel Nicolaus on Thursday, February 1. Barclays Capital maintained the shares of ST in report on Monday, October 5 with “Overweight” rating. As per Friday, November 13, the company rating was downgraded by SunTrust. Cowen & Co maintained Sensata Technologies Holding PLC (NYSE:ST) on Thursday, July 20 with “Hold” rating. RBC Capital Markets maintained the shares of ST in report on Thursday, August 31 with “Buy” rating.

Saturna Capital Corp decreased Adobe Systems (NASDAQ:ADBE) stake by 50,120 shares to 486,710 valued at $85.29M in 2017Q4. It also reduced Starbucks (NASDAQ:SBUX) stake by 6,686 shares and now owns 24,283 shares. Cvs Health (NYSE:CVS) was reduced too.

More important recent Sensata Technologies Holding PLC (NYSE:ST) news were published by: Seekingalpha.com which released: “Tracking Glenn Greenberg’s Brave Warrior Advisors Portfolio – Q1 2018 Update” on May 18, 2018, also Globenewswire.com published article titled: “Sensata Technologies Reports First Quarter 2018 Financial Results”, Globenewswire.com published: “Sensata Technologies to Present at Wells Fargo Industrials Conference” on May 04, 2018. More interesting news about Sensata Technologies Holding PLC (NYSE:ST) was released by: Seekingalpha.com and their article: “Sensata Technologies beat Q1 estimates” with publication date: April 24, 2018.

Sensata Technologies Holding PLC (NYSE:ST) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: